论文部分内容阅读
摘要:目的:通过230例原发性肝癌的介入治疗,研究其疗效及影响因素。材料与方法:回顾性分析230例肝癌肝动脉化疗、栓塞的临床随访资料。结果:总疗效为症状缓解占69.1％,肿瘤缩小占62.6％,AFP下降44.8％。半年、1、2、3年生存率分别为80.9％、51.3％、30％、18.7％。对比分析了肿瘤的大小、门脉癌栓的有无及治疗方法等影响疗效的有关因素。结论:肝癌的介入治疗疗效明显优于其他非手术疗法,早中期、单个肿瘤、直径<10cm、无门脉癌栓或肝动静脉瘘、治疗2次以上及栓塞完全者,疗效明显优于对应组。综合治疗将会进一步提高肝癌化疗栓塞的疗效。
Abstract : Objective: To study the curative effect and influencing factors of 230 patients with primary liver cancer. Materials and Methods: Clinical follow-up data of 230 cases of hepatic artery chemotherapy and embolization were retrospectively analyzed. Results: The total effect was 69.1% for symptomatic relief, 62.6% for tumor reduction, and 44.8% for AFP. The half-year, 1-, 2-, and 3-year survival rates were 80.9%, 51.3%, 30%, and 18.7%, respectively. Comparative analysis of factors such as the size of the tumor, the presence or absence of a portal vein tumor thrombus, and treatment methods affect the efficacy. Conclusion: The curative effect of interventional treatment of liver cancer is obviously better than other non-surgical treatments. The curative effect is better than the corresponding in early and mid-term, single tumor, diameter less than 10cm, portal vein tumor thrombus or hepatic arteriovenous fistula, treatment more than 2 times and complete embolization. group. Comprehensive treatment will further improve the efficacy of hepatocellular carcinoma chemoembolization.